HCA Healthcare (HCA) DIvidends Date & History

Key Takeaways

• HCA Healthcare (HCA) pays a quarterly dividend of $0.78 per share, equating to an annual payout of $3.12 and a yield of 0.66%.
• The payout ratio hovers around 10-11%, supported by trailing twelve-month EPS of $28.35, signaling excellent coverage.
• Dividend has grown consistently for over six years, with an 8% increase in early 2026 from $0.72 to $0.78 per share.
• Strong free cash flow generation, with Q1 2026 operating cash flows at $2.0 billion, underpins dividend sustainability.
• Yield trails broader healthcare sector average of ~1.9% but exceeds key hospital peers like UHS (0.45%).
• Recent ex-dividend date was March 17, 2026; next expected June 16, 2026.

Dividend Overview

HCA Healthcare (HCA), the largest U.S. hospital operator, maintains a modest dividend policy focused on steady growth rather than high yield. The company currently offers a quarterly dividend of $0.78 per share, announced in its Q1 2026 earnings, resulting in an annualized dividend of $3.12 and a yield of approximately 0.66% based on recent stock prices. Payments occur quarterly, with the most recent ex-dividend date on March 17, 2026, and payment on March 31, 2026. The next is slated for ex-date June 16, 2026, payable June 30, 2026. This profile positions HCA as a dividend growth stock, prioritizing reinvestment in operations and expansions while rewarding shareholders with reliable increases amid robust earnings growth.

Dividend History and Growth

HCA Healthcare has demonstrated consistent dividend growth since resuming regular quarterly payments around 2018, following earlier special dividends in 2012. Starting at $0.35 per share in early 2018, the quarterly payout has risen steadily: to $0.40 (2019), $0.48 (2021), $0.56 (2022), $0.60 (2023), $0.66 (2024), $0.72 (2025), and $0.78 in 2026—an 8% year-over-year increase. This equates to over six consecutive years of raises, with a five-year compound annual growth rate exceeding 35% in some metrics. No cuts have occurred during this period, reflecting a long-term strategy of balancing growth investments with shareholder returns through escalating payouts supported by operational expansion.

Dividend Sustainability and Payout Ratio

The dividend's sustainability is robust, underscored by a low payout ratio of about 10-11%—far below the 60% threshold often viewed as prudent for growth companies. With trailing EPS at $28.35 and annual dividend at $3.12, earnings coverage exceeds 9x. Free cash flow remains strong, with 2024 full-year FCF at $5.6 billion and Q1 2026 operating cash flows surging 22% to $2.0 billion despite $1.1 billion in capex. Balance sheet stability, fueled by revenue growth (4.3% in Q1 2026 to $19.1 billion) and high margins, supports ongoing payments. Debt levels, typical for capital-intensive healthcare, are manageable given cash generation, positioning the dividend for continued growth without strain.

Dividend Compared to Industry Peers

HCA Healthcare's 0.66% yield is modest compared to the broader healthcare sector average of around 1.93%, where pharmaceutical giants offer higher payouts. However, within acute care hospitals and facilities, it shines: rival THC (Tenet Healthcare) pays no dividend, UHS (Universal Health Services) yields 0.45%, and CYH (Community Health Systems) offers none. EHC (Encompass Health) provides a similar low yield profile. HCA's edge lies in its superior growth trajectory and coverage, making it competitive for peers prioritizing reinvestment over income.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It excels at identifying dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to uncover healthcare dividend plays like HCA.

Is This Stock Attractive for Dividend Investors?

HCA Healthcare appeals to dividend growth investors seeking healthcare sector exposure with potential for capital appreciation over high current income. Its low 0.66% yield may deter strict income seekers, but consistent raises—now over six years—coupled with a sub-11% payout ratio and strong cash flows make it suitable for those prioritizing total returns. Long-term holders valuing operational scale (186 hospitals) and resilience amid aging demographics could find appeal, especially versus non-dividend peers like THC. Conservative investors might appreciate the earnings buffer, though growth-oriented profiles suit its reinvestment focus. Balanced portfolios blending yield and upside may benefit, but volatility from healthcare regulations warrants caution. Suitability varies by risk tolerance and goals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations